ICLR 250417 175.00C(ICLR250417C175000) Stock Price Today

US OptionsDetailed Quotes

ICLR250417C175000

Watchlist

0.98
-0.17-14.78%

15min DelayClose Apr 7 16:00 ET

1.24High0.98Low

Intraday

5D
Daily

News

Icon Price Target Cut to $215.00/Share From $290.00 by Citigroup
Dow JonesApr 7 11:52 ET · Ratings
Express News | Citigroup Maintains Buy on Icon, Lowers Price Target to $215
BenzingaApr 7 11:42 ET
Does ICON (NASDAQ:ICLR) Have A Healthy Balance Sheet?
Simply Wall StApr 7 09:24 ET
Express News | ICON PLC : Citigroup Cuts Target Price to $215 From $290
ReutersApr 7 06:57 ET
Anne Whitaker Appointed as Non-Executive Director
GlobeNewswireApr 3 18:13 ET
LVS Advisory Sold Icon Plc (ICLR) After Identifying Flaws in Its Investment Thesis
Yahoo FinanceApr 3 10:03 ET

Comments

Teddy123

Mar 20 18:39

ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management and Review

$Icon PLC (ICLR.US)$
Major Breakthrough: ICON Leads Clinical Research Evolution with AI-Powered Medidata Platform

Stock_Drift

Jan 30 21:00

$Icon PLC (ICLR.US)$

Moomoo AI

Oct 28, 2023 20:46

While ICON's earnings forecast dipped slightly, the consensus price target remains unchanged. Despite the slower expected revenue growth, ICON is still predicted to outperform the wider industry growth.

ICON Public Limited Company (NASDAQ:ICLR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Analysts Notebook

May 24, 2022 19:18

Columns Top upgrades and downgrades on 5/24

Upgrades
• $Marqeta (MQ.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $15
• $Northwest Natural (NWN.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51)
• $Otis Worldwide (OTIS.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80)
• $Snowflake (SNOW.US)$ : Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325)
Downgrades
• $Eaton (ETN.US)$ : Barclays Downgrades to Underweight from Eq...